<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml producer="poppler" version="23.12.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="600">
	<fontspec id="0" size="10" family="Minion" color="#231f20"/>
	<fontspec id="1" size="9" family="Minion" color="#231f20"/>
	<fontspec id="2" size="9" family="Minion" color="#231f20"/>
	<fontspec id="3" size="6" family="Minion" color="#231f20"/>
	<fontspec id="4" size="9" family="Minion" color="#231f20"/>
	<fontspec id="5" size="6" family="MinionProMath" color="#231f20"/>
	<fontspec id="6" size="9" family="MinionExp" color="#231f20"/>
	<fontspec id="7" size="8" family="LucidaNewMath-Symbol" color="#231f20"/>
	<fontspec id="8" size="8" family="Minion" color="#231f20"/>
	<fontspec id="9" size="8" family="Minion" color="#000000"/>
	<fontspec id="10" size="8" family="Minion" color="#231f20"/>
	<fontspec id="11" size="8" family="MinionExp" color="#231f20"/>
	<fontspec id="12" size="10" family="Minion" color="#231f20"/>
	<fontspec id="13" size="10" family="Minion" color="#000000"/>
	<fontspec id="14" size="10" family="MinionExp" color="#231f20"/>
	<fontspec id="15" size="12" family="Minion-Black" color="#231f20"/>
	<fontspec id="16" size="10" family="MinionProMath" color="#231f20"/>
	<fontspec id="17" size="7" family="MinionProMath" color="#231f20"/>
	<fontspec id="18" size="9" family="LucidaNewMath-Symbol" color="#231f20"/>
	<fontspec id="19" size="10" family="MinionExp" color="#231f20"/>
<text top="45" left="51" width="5" height="9" font="0">2</text>
<text top="45" left="463" width="85" height="9" font="0">Journal of Toxicology</text>
<text top="74" left="51" width="240" height="9" font="1">Table 1: Chemical-specific parameters used in the steady-state</text>
<text top="84" left="51" width="38" height="9" font="2">algorithm.</text>
<text top="105" left="53" width="37" height="9" font="2">Parameter</text>
<text top="99" left="213" width="34" height="9" font="2">Chemical</text>
<text top="113" left="170" width="30" height="9" font="2">Benzene</text>
<text top="112" left="200" width="7" height="6" font="3">(a)</text>
<text top="113" left="233" width="44" height="9" font="2">1,4-Dioxane</text>
<text top="112" left="277" width="8" height="6" font="3">(b)</text>
<text top="126" left="53" width="22" height="9" font="4"><i>V</i>max</text>
<text top="130" left="75" width="2" height="6" font="3">c</text>
<text top="126" left="80" width="34" height="9" font="2">(mg/h-kg</text>
<text top="125" left="114" width="3" height="6" font="3">0</text>
<text top="124" left="117" width="1" height="8" font="5"><i>.</i></text>
<text top="125" left="118" width="6" height="6" font="3">75</text>
<text top="126" left="125" width="3" height="9" font="2">)</text>
<text top="126" left="181" width="15" height="9" font="2">2.11</text>
<text top="126" left="252" width="15" height="9" font="2">0.27</text>
<text top="137" left="53" width="41" height="9" font="2">Km (mg/L)</text>
<text top="137" left="183" width="11" height="9" font="2">0.1</text>
<text top="137" left="254" width="11" height="9" font="2">3.0</text>
<text top="148" left="53" width="70" height="9" font="2">Blood : air partition</text>
<text top="158" left="53" width="12" height="9" font="2">coe</text>
<text top="156" left="65" width="7" height="12" font="6">ﬃ</text>
<text top="158" left="72" width="28" height="9" font="2">cient (<i>P</i></text>
<text top="160" left="100" width="3" height="8" font="5"><i>b</i></text>
<text top="158" left="103" width="3" height="9" font="2">)</text>
<text top="153" left="183" width="11" height="9" font="2">7.4</text>
<text top="153" left="250" width="17" height="9" font="2">3650</text>
<text top="169" left="53" width="86" height="9" font="2">Exposure concentration</text>
<text top="179" left="53" width="25" height="9" font="2">(mg/m</text>
<text top="178" left="78" width="3" height="6" font="3">3</text>
<text top="179" left="81" width="15" height="9" font="2">, UF</text>
<text top="178" left="99" width="6" height="10" font="7"><i>×</i></text>
<text top="179" left="107" width="17" height="9" font="2">RfC)</text>
<text top="178" left="124" width="7" height="6" font="3">(c)</text>
<text top="174" left="183" width="11" height="9" font="2">0.3</text>
<text top="174" left="257" width="4" height="9" font="2">3</text>
<text top="191" left="52" width="7" height="6" font="3">(a)</text>
<text top="192" left="59" width="3" height="8" font="8"><a href="">[</a></text>
<text top="192" left="62" width="8" height="8" font="9"><a href="">22</a></text>
<text top="192" left="70" width="5" height="8" font="8">].</text>
<text top="191" left="78" width="8" height="6" font="3">(b)</text>
<text top="192" left="86" width="3" height="8" font="8"><a href="">[</a></text>
<text top="192" left="89" width="8" height="8" font="9"><a href="">23</a></text>
<text top="192" left="97" width="5" height="8" font="8"><a href="">].</a></text>
<text top="191" left="104" width="7" height="6" font="3">(c)</text>
<text top="192" left="112" width="3" height="8" font="8"><a href="">[</a></text>
<text top="192" left="115" width="8" height="8" font="9"><a href="">10</a></text>
<text top="192" left="122" width="5" height="8" font="8">].</text>
<text top="201" left="51" width="171" height="8" font="8">BW: body weight; Km: Micha¨elis-Menten constant, <i>P</i></text>
<text top="203" left="221" width="3" height="8" font="5"><i>b</i></text>
<text top="201" left="225" width="66" height="8" font="8">: blood : air partition</text>
<text top="211" left="51" width="11" height="8" font="8">coe</text>
<text top="209" left="61" width="7" height="10" font="11">ﬃ</text>
<text top="211" left="68" width="223" height="8" font="8">cient, RfC: reference concentration; UF: interindividual uncertainty</text>
<text top="220" left="51" width="42" height="8" font="8">factor; <i>V</i>max</text>
<text top="223" left="93" width="2" height="6" font="3">c</text>
<text top="220" left="96" width="130" height="8" font="8">: constant maximum rate of metabolism.</text>
<text top="245" left="51" width="240" height="9" font="0">value of a parameter (i.e., 95th) and its central tendency value</text>
<text top="256" left="51" width="240" height="9" font="0">(i.e<i>.</i>, median) in the whole population or between an upper</text>
<text top="267" left="51" width="240" height="9" font="0">percentile value in a presumed susceptible subpopulation</text>
<text top="279" left="51" width="240" height="9" font="0">and the central tendency value in the general healthy</text>
<text top="290" left="51" width="50" height="9" font="0">population <a href="">[</a></text>
<text top="290" left="101" width="5" height="9" font="13"><a href="">8</a></text>
<text top="290" left="106" width="2" height="9" font="0"><a href="">,</a></text>
<text top="290" left="110" width="5" height="9" font="13"><a href="">9</a></text>
<text top="290" left="115" width="6" height="9" font="0">].</text>
<text top="301" left="66" width="163" height="9" font="0">Neither the historical definitions of IVF <a href="">[</a></text>
<text top="301" left="229" width="5" height="9" font="13"><a href="">4</a></text>
<text top="301" left="233" width="57" height="9" font="0">] nor the IPCS</text>
<text top="313" left="51" width="125" height="9" font="0">guidance document on CSAFs <a href="">[</a></text>
<text top="313" left="175" width="5" height="9" font="13"><a href="">8</a></text>
<text top="313" left="180" width="111" height="9" font="0">] clearly defines the “average</text>
<text top="324" left="51" width="240" height="9" font="0">healthy individual,” forming the point of comparison for</text>
<text top="336" left="51" width="240" height="9" font="0">the presumed sensitive subpopulations. Particularly, it is</text>
<text top="347" left="51" width="240" height="9" font="0">unclear as to whether this individual is the average healthy</text>
<text top="358" left="51" width="240" height="9" font="0">adult or the average healthy individual from the whole</text>
<text top="370" left="51" width="240" height="9" font="0">population (which includes both healthy adults and sensitive</text>
<text top="381" left="51" width="240" height="9" font="0">subpopulations). But presumably because the POD used to</text>
<text top="392" left="51" width="240" height="9" font="0">derive the RfD or RfC is generally determined in healthy</text>
<text top="404" left="51" width="120" height="9" font="0">adults (animal or human) <a href="">[</a></text>
<text top="404" left="171" width="10" height="9" font="13"><a href="">10</a></text>
<text top="404" left="181" width="110" height="9" font="0"><a href="">], </a>HKAF evaluations con-</text>
<text top="415" left="51" width="174" height="9" font="0">ducted using experimental data for drugs <a href="">[</a></text>
<text top="415" left="225" width="10" height="9" font="13"><a href="">11</a></text>
<text top="415" left="234" width="5" height="9" font="0"><a href="">–</a></text>
<text top="415" left="239" width="10" height="9" font="13"><a href="">13</a></text>
<text top="415" left="249" width="42" height="9" font="0"><a href="">] </a>or PBPK</text>
<text top="427" left="51" width="212" height="9" font="0">model simulation data for environmental toxicants <a href="">[</a></text>
<text top="427" left="263" width="10" height="9" font="13"><a href="">14</a></text>
<text top="427" left="273" width="5" height="9" font="0"><a href="">–</a></text>
<text top="427" left="278" width="10" height="9" font="13"><a href="">16</a></text>
<text top="427" left="287" width="4" height="9" font="0">]</text>
<text top="438" left="51" width="240" height="9" font="0">have relied on what can be called a “distinct subpopulation”</text>
<text top="449" left="51" width="240" height="9" font="0">approach. Thus, the experimental or simulated data in the</text>
<text top="461" left="51" width="240" height="9" font="0">presumed susceptible individuals (e.g., neonates, pregnant</text>
<text top="472" left="51" width="240" height="9" font="0">women, elderly, polymorphic individuals) have often been</text>
<text top="483" left="51" width="225" height="9" font="0">compared with the corresponding data in healthy adults.</text>
<text top="495" left="66" width="225" height="9" font="0">Alternatively, HKAF can be quantified using a “whole</text>
<text top="506" left="51" width="240" height="9" font="0">population” approach as done recently by M¨ork and Johan-</text>
<text top="517" left="51" width="21" height="9" font="0">son <a href="">[</a></text>
<text top="517" left="72" width="10" height="9" font="13"><a href="">17</a></text>
<text top="517" left="82" width="209" height="9" font="0"><a href="">]. </a>In this study, HKAFs were calculated for inhaled</text>
<text top="529" left="51" width="240" height="9" font="0">acetone based on a simulated distribution of steady-state</text>
<text top="540" left="51" width="240" height="9" font="0">blood concentration in an entire population, including</text>
<text top="552" left="51" width="240" height="9" font="0">adults and various age-defined groups of children. The PBPK</text>
<text top="563" left="51" width="107" height="9" font="0">modeling results in the di</text>
<text top="561" left="158" width="6" height="13" font="14">ﬀ</text>
<text top="563" left="163" width="127" height="9" font="0">erent subgroups were weighted</text>
<text top="574" left="51" width="240" height="9" font="0">according to demographic representation in Sweden. Exclud-</text>
<text top="586" left="51" width="240" height="9" font="0">ing the endogenous production of acetone, an HKAF of 1.9</text>
<text top="597" left="51" width="240" height="9" font="0">was obtained by dividing the 95th percentile value of the</text>
<text top="608" left="51" width="240" height="9" font="0">entire population by the median. In comparison, using the</text>
<text top="620" left="51" width="240" height="9" font="0">95th percentile value of that same dose metric in 3-month-</text>
<text top="631" left="51" width="240" height="9" font="0">old babies as well as 10 and 15 yr old children resulted in</text>
<text top="643" left="51" width="150" height="9" font="0">HKAFs of 2, 2.4, and 1.7, respectively.</text>
<text top="654" left="66" width="225" height="9" font="0">The hypothesis that the HKAF determined upon the</text>
<text top="665" left="51" width="160" height="9" font="0">“whole population” approach is quite di</text>
<text top="663" left="211" width="6" height="13" font="14">ﬀ</text>
<text top="665" left="216" width="75" height="9" font="0">erent from the one</text>
<text top="677" left="51" width="240" height="9" font="0">determined based on the “distinct subpopulation” approach</text>
<text top="688" left="51" width="203" height="9" font="0">stems from the results of M¨ork and Johanson <a href="">[</a></text>
<text top="688" left="253" width="10" height="9" font="13"><a href="">17</a></text>
<text top="688" left="263" width="28" height="9" font="0"><a href="">]. </a>This</text>
<text top="699" left="51" width="47" height="9" font="0">potential di</text>
<text top="697" left="98" width="6" height="13" font="14">ﬀ</text>
<text top="699" left="104" width="187" height="9" font="0">erence could be significant from a regulatory</text>
<text top="711" left="51" width="240" height="9" font="0">standpoint because it may not lead to comparable levels</text>
<text top="722" left="51" width="104" height="9" font="0">of protection for the di</text>
<text top="720" left="155" width="6" height="13" font="14">ﬀ</text>
<text top="722" left="161" width="130" height="9" font="0">erent subgroups that compose</text>
<text top="733" left="51" width="240" height="9" font="0">the whole population. It is also not known whether the</text>
<text top="74" left="309" width="240" height="9" font="0">population composition and the chemical considered may</text>
<text top="85" left="309" width="97" height="9" font="0">impact this potential di</text>
<text top="83" left="406" width="6" height="13" font="14">ﬀ</text>
<text top="85" left="411" width="138" height="9" font="0">erence. Thus, the objective of the</text>
<text top="97" left="309" width="240" height="9" font="0">current study was to evaluate the magnitude and adequacy of</text>
<text top="108" left="309" width="240" height="9" font="0">the HKAFs determined by the “whole population” approach</text>
<text top="119" left="309" width="240" height="9" font="0">as compared to the “distinct subpopulation” approach. In</text>
<text top="131" left="309" width="4" height="9" font="0">e</text>
<text top="128" left="313" width="6" height="13" font="14">ﬀ</text>
<text top="131" left="319" width="230" height="9" font="0">ect, population distributions of internal dose metrics</text>
<text top="142" left="309" width="240" height="9" font="0">following chronic exposure to two chemicals exhibiting</text>
<text top="154" left="309" width="8" height="9" font="0">di</text>
<text top="151" left="317" width="6" height="13" font="14">ﬀ</text>
<text top="154" left="322" width="227" height="9" font="0">erent clearance characteristics were used to compute the</text>
<text top="165" left="309" width="36" height="9" font="0">HKAF as</text>
<text top="185" left="326" width="223" height="9" font="0">(i) the ratio of the upper percentile value in the entire</text>
<text top="196" left="339" width="210" height="9" font="0">population including adults and nonadults over the</text>
<text top="208" left="339" width="186" height="9" font="0">median in adults and in this entire population;</text>
<text top="224" left="323" width="226" height="9" font="0">(ii) the ratio of the upper percentile value in presumed</text>
<text top="236" left="339" width="210" height="9" font="0">susceptible subpopulation over the median in adults</text>
<text top="247" left="339" width="210" height="9" font="0">and in the entire population including adults and</text>
<text top="258" left="339" width="46" height="9" font="0">non-adults.</text>
<text top="285" left="309" width="56" height="11" font="15"><b>2. Methods</b></text>
<text top="306" left="309" width="240" height="9" font="0">A physiologically based steady-state algorithm combined</text>
<text top="318" left="309" width="240" height="9" font="0">with Monte Carlo simulation software was used to generate</text>
<text top="329" left="309" width="240" height="9" font="0">population distributions of blood concentration (CAss) and</text>
<text top="340" left="309" width="240" height="9" font="0">rate of metabolism (RAM) for chronic inhalation exposure</text>
<text top="352" left="309" width="240" height="9" font="0">to two chemicals with contrasting systemic clearance char-</text>
<text top="363" left="309" width="240" height="9" font="0">acteristics. The population distributions were reconstructed</text>
<text top="374" left="309" width="47" height="9" font="0">based on di</text>
<text top="372" left="355" width="6" height="13" font="14">ﬀ</text>
<text top="374" left="361" width="188" height="9" font="0">erent proportions of randomly selected adults,</text>
<text top="386" left="309" width="240" height="9" font="0">elderly, children, neonates, and PW, and they were used to</text>
<text top="397" left="309" width="240" height="9" font="0">compute HKAFs based on “whole population” and “distinct</text>
<text top="409" left="309" width="112" height="9" font="0">subpopulation” approaches.</text>
<text top="435" left="309" width="240" height="9" font="12"><i>2.1. Selection of Surrogate Chemicals and Their Specific</i></text>
<text top="446" left="309" width="240" height="9" font="12"><i>Parameters. </i>Two VOCs were chosen as surrogate chemicals</text>
<text top="457" left="309" width="240" height="9" font="0">because they exhibit contrasting systemic clearances based</text>
<text top="469" left="309" width="172" height="9" font="0">on their pulmonary clearance potential (di</text>
<text top="466" left="480" width="6" height="13" font="14">ﬀ</text>
<text top="469" left="486" width="63" height="9" font="0">erent blood : air</text>
<text top="480" left="309" width="53" height="9" font="0">partition coe</text>
<text top="478" left="361" width="8" height="13" font="14">ﬃ</text>
<text top="480" left="369" width="27" height="9" font="0">cient (</text>
<text top="478" left="396" width="6" height="13" font="16"><i>P</i></text>
<text top="482" left="402" width="3" height="9" font="17"><i>b</i></text>
<text top="480" left="406" width="143" height="9" font="0">)) and their hepatic clearance (dif-</text>
<text top="491" left="309" width="240" height="9" font="0">ferent hepatic extraction ratios). Benzene was chosen as an</text>
<text top="503" left="309" width="240" height="9" font="0">extensively cleared chemical because of its high pulmonary</text>
<text top="514" left="309" width="59" height="9" font="0">clearance (low</text>
<text top="512" left="372" width="6" height="13" font="16"><i>P</i></text>
<text top="516" left="378" width="3" height="9" font="17"><i>b</i></text>
<text top="514" left="382" width="167" height="9" font="0">, 7.4) and high hepatic extraction ratio.</text>
<text top="526" left="309" width="240" height="9" font="0">Conversely, 1,4-dioxane was chosen as a poorly cleared</text>
<text top="537" left="309" width="191" height="9" font="0">chemical due to its low pulmonary clearance (</text>
<text top="534" left="500" width="6" height="13" font="16"><i>P</i></text>
<text top="539" left="506" width="3" height="9" font="17"><i>b</i></text>
<text top="535" left="514" width="7" height="12" font="18"><i>=</i></text>
<text top="537" left="526" width="23" height="9" font="0">3650)</text>
<text top="548" left="309" width="240" height="9" font="0">and low hepatic extraction ratio. While benzene is a known</text>
<text top="560" left="309" width="97" height="9" font="0">substrate of CYP2E1 <a href="">[</a></text>
<text top="560" left="406" width="10" height="9" font="13"><a href="">18</a></text>
<text top="560" left="416" width="133" height="9" font="0"><a href="">], </a>for which extensive data on</text>
<text top="571" left="309" width="160" height="9" font="0">interindividual variability are available <a href="">[</a></text>
<text top="571" left="469" width="10" height="9" font="13"><a href="">19</a></text>
<text top="571" left="479" width="2" height="9" font="0"><a href="">,</a></text>
<text top="571" left="484" width="10" height="9" font="13"><a href="">20</a></text>
<text top="571" left="493" width="56" height="9" font="0">], 1,4-dioxane</text>
<text top="582" left="309" width="240" height="9" font="0">was included in this study to facilitate the coverage of a range</text>
<text top="594" left="309" width="240" height="9" font="0">of physico/biochemical properties of potential substrates of</text>
<text top="605" left="309" width="39" height="9" font="0">CYP2E1 <a href="">[</a></text>
<text top="605" left="348" width="10" height="9" font="13"><a href="">21</a></text>
<text top="605" left="358" width="191" height="9" font="0"><a href="">]. </a>Chemical-specific parameters are indicated in</text>
<text top="616" left="309" width="28" height="9" font="13"><a href="">Table 1</a></text>
<text top="616" left="340" width="145" height="9" font="0">and were taken from the literature <a href="">[</a></text>
<text top="616" left="485" width="10" height="9" font="13"><a href="">10</a></text>
<text top="616" left="495" width="2" height="9" font="0"><a href="">,</a></text>
<text top="616" left="500" width="10" height="9" font="13"><a href="">22</a></text>
<text top="616" left="509" width="2" height="9" font="0">,</text>
<text top="616" left="515" width="10" height="9" font="13"><a href="">23</a></text>
<text top="616" left="524" width="25" height="9" font="0">]. The</text>
<text top="628" left="309" width="240" height="9" font="0">choice of these two surrogate VOCs and associated kinetic</text>
<text top="639" left="309" width="240" height="9" font="0">parameters was undertaken to reflect the range of kinetic</text>
<text top="651" left="309" width="240" height="9" font="0">characteristics of hypothetical substances for evaluating the</text>
<text top="662" left="309" width="240" height="9" font="0">HKAF. As such, the present modeling study did not focus</text>
<text top="673" left="309" width="240" height="9" font="0">on any aspect of the risk assessment relating to these specific</text>
<text top="685" left="309" width="41" height="9" font="0">chemicals.</text>
<text top="711" left="309" width="240" height="9" font="12"><i>2.2. Use of a Biologically Based Steady-State Model for the</i></text>
<text top="722" left="309" width="216" height="9" font="12"><i>Simulation of Continuous Inhalation Exposure in Di</i></text>
<text top="720" left="524" width="5" height="13" font="19"><i>ﬀ</i></text>
<text top="722" left="529" width="19" height="9" font="12"><i>erent</i></text>
<text top="733" left="309" width="240" height="9" font="12"><i>Subpopulations. </i>The current study relies on the use of</text>
</page>
</pdf2xml>
